Viemed Healthcare Completes Acquisition of Lehan’s Medical Equipment

Viemed Healthcare ( (VMD) ) has shared an announcement.

On July 2, 2025, Viemed Healthcare announced the completion of its acquisition of Lehan’s Medical Equipment, a provider of home medical equipment based in Illinois, for a base purchase price of $26 million plus contingent payments. This acquisition is expected to enhance Viemed’s market presence by combining Lehan’s established brand and expertise with Viemed’s national scale and care delivery model. Viemed plans to update its full-year 2025 financial guidance to reflect the acquisition’s contribution when reporting earnings for the quarter ended June 30, 2025.

The most recent analyst rating on (VMD) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Viemed Healthcare stock, see the VMD Stock Forecast page.

Spark’s Take on VMD Stock

According to Spark, TipRanks’ AI Analyst, VMD is a Outperform.

Viemed Healthcare is a moderately attractive investment with strong financial performance and strategic initiatives. The positive earnings outlook and corporate events enhance its appeal, despite technical indicators suggesting potential caution. Investors should monitor profitability improvements and capital management.

To see Spark’s full report on VMD stock, click here.

More about Viemed Healthcare

Viemed Healthcare, Inc. is an in-home clinical care provider specializing in post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators, sleep therapy, staffing, and other complementary products and services. The company focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education, and counseling to patients in their homes using high-touch and high-tech services.

Average Trading Volume: 181,996

Technical Sentiment Signal: Sell

Current Market Cap: $276.7M

Find detailed analytics on VMD stock on TipRanks’ Stock Analysis page.